Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin Plus Alternating Weekly Temozolomide in Recurrent High-grade Gliomas
NCT02263105Phase 2Completed
- Sponsor
- Huashan Hospital
- Start
- Oct 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in glioma, sponsored by Huashan Hospital. Started Oct 2014; status: completed.
02
Drugs
cisplatin
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02263105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263105.